InsidersTradesSigma
Track the 경동제약 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 경동제약 has recorded 1 public disclosures. Market capitalisation: €142.1bn. The latest transaction was filed on 3 April 2026 (Purchase). Among the most active insiders: 류 기 성. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
경동제약 是一家在 XKRX 交易所上市的健康和制药领域的公司。它专注于药品的研发和制造。